A DeepMind study finds LLMs are both stubborn and easily swayed. This confidence paradox has key implications for building AI applications.

Scientists from OpenAI, Google, Anthropic and Meta unite in rare collaboration to warn that a critical window for monitoring AI reasoning may close forever as models learn to hide their thoughts.

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Google’s AI agent, dubbed Big Sleep, has achieved a cybersecurity milestone by detecting and blocking an imminent exploit in the wild—marking the first time an AI has proactively foiled a cyber threat ...

Device, a vision-language-action (VLA) foundation model designed to run locally on robot hardware. The model features ...

Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery. With tech-enabled therapies evolving fast, new inflection points spell a ...

Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...

Bill Gates has warned that AI will replace many jobs, but says coding will stay a fully human profession, even hundreds of ...

Elon Musk recently introduced Grok 4, the newest iteration of xAI's foundation model, describing it as a "maximally truth-seeking AI." According to critics, the model seems ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Google today enhanced its Veo 3 AI model with a new image-to-video capability, allowing users to transform a single photo into an eight-second video clip with sound. The feature is now rolling out to ...

Google DeepMind subsidiary, Isomorphic Labs, has said it is ready to conduct human trials for drugs developed using its AlphaFold AI technology.